Dose Optimization of Pembrolizumab: Less May Be More

Mark J. Ratain*, Cody J. Peer, William D. Figg, Daniel A. Goldstein

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)993
Number of pages1
JournalClinical Pharmacology and Therapeutics
Volume111
Issue number5
DOIs
StatePublished - May 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dose Optimization of Pembrolizumab: Less May Be More'. Together they form a unique fingerprint.

Cite this